Manipal AcuNova acquires German firm Ecron

BANGALORE: Clinical research firm Manipal AcuNova Ltd on Monday announced it has completed the acquisition of ECRON GmbH, Europe.

The new entity ECRON AcuNova will provide end-to-end services for Phase I - IV clinical trials including project management, clinical data management, biostatistics, medical writing, central lab and bio-availability/bio equivalence (BA/BE) studies to pharma, biotech, device and diagnostic companies, a MAL statement said.

The combined strength will be 265 employees and the company will increase headcount evry year. Frankfurt will be European HQ, Princeton for the US and Bangalore for Asia.

Dr Wiedey, President, ECRON said: "This collaboration will benefit our European and US clients. The possibility of extending trials from Europe to India will make drug development faster... . We can take up bigger complex projects with a broader range of services like central lab and PK/PD service".